Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptorsAdriano Mollica, Romano Silvestri, Sveva Pelliccia et al.|Journal of Enzyme Inhibition and Medicinal Chemistry|2017Cited by 39
Combined Peptide and Small-Molecule Approach toward Nonacidic THIQ Inhibitors of the KEAP1/NRF2 InteractionJesus M. Ontoria, Steven J. Harper, Esther Torrente et al.|ACS Medicinal Chemistry Letters|2020Cited by 29